HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Apr 17, 2024, 2:36 PM EDT - Market closed
HTG Molecular Diagnostics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.37 | 8.91 | 8.55 | 19.2 | 21.5 | 14.76 | 5.13 | 4.04 | 3.33 | 2.24 | Upgrade
|
Revenue Growth (YoY) | -28.52% | 4.19% | -55.48% | -10.70% | 45.69% | 187.56% | 27.00% | 21.41% | 48.41% | -9.58% | Upgrade
|
Cost of Revenue | 4.57 | 4.09 | 3.99 | 8.91 | 5.09 | 4.97 | 4.14 | 3.34 | 3.2 | 2.25 | Upgrade
|
Gross Profit | 1.79 | 4.81 | 4.56 | 10.29 | 16.41 | 9.79 | 1 | 0.71 | 0.12 | -0 | Upgrade
|
Selling, General & Admin | 15.84 | 16.55 | 18.06 | 18.68 | 19.97 | 17.51 | 17.43 | 14.99 | 9.9 | 7.71 | Upgrade
|
Research & Development | 6.78 | 6.09 | 6.08 | 10.57 | 12.6 | 10 | 7.9 | 4.6 | 3.08 | 4.2 | Upgrade
|
Other Operating Expenses | 0.01 | -1.03 | 0.02 | 0 | 0 | -1.23 | 0.06 | -0.62 | -0.01 | 0.2 | Upgrade
|
Operating Expenses | 22.62 | 22.64 | 24.14 | 29.25 | 32.57 | 27.51 | 25.33 | 19.6 | 12.97 | 11.91 | Upgrade
|
Operating Income | -20.83 | -17.82 | -19.59 | -18.96 | -16.16 | -17.72 | -24.33 | -18.89 | -12.85 | -11.92 | Upgrade
|
Interest Income | 0.09 | 0.03 | 0.25 | 0.62 | 0.72 | 0.07 | 0.11 | 0.09 | 0 | 0 | Upgrade
|
Interest Expense | 0.86 | 1.06 | 1.02 | 0.96 | 0.9 | 1.31 | 1.76 | 1.63 | 0.71 | 0.21 | Upgrade
|
Other Expense / Income | -0.01 | -1.74 | 0.5 | - | 0.11 | -0 | 0.06 | 0.95 | -0.29 | -0.77 | Upgrade
|
Pretax Income | -21.58 | -17.12 | -20.86 | -19.29 | -16.45 | -18.96 | -26.03 | -21.39 | -13.96 | -11.77 | Upgrade
|
Income Tax | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 | 0.01 | 0.01 | 0.69 | 0.41 | Upgrade
|
Net Income | -21.59 | -17.15 | -20.87 | -19.3 | -16.45 | -18.96 | -26.04 | -21.4 | -13.96 | -11.77 | Upgrade
|
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change | 53.85% | 49.88% | 82.20% | 38.43% | 159.72% | 48.98% | 57.43% | 1255.40% | - | - | Upgrade
|
EPS (Basic) | -24.28 | -29.66 | -54.12 | -91.17 | -107.61 | -322.04 | -658.95 | -852.43 | -7536.94 | -6354.98 | Upgrade
|
EPS (Diluted) | -24.28 | -29.66 | -54.12 | -91.17 | -107.61 | -322.04 | -658.95 | -852.43 | -7536.94 | -6354.98 | Upgrade
|
Free Cash Flow | -18.43 | -17.15 | -16.75 | -17.8 | -14.12 | -17.59 | -24.18 | -20.58 | -13.85 | -12.6 | Upgrade
|
Free Cash Flow Per Share | -20.73 | -29.68 | -43.42 | -84.09 | -92.37 | -298.82 | -611.91 | -819.91 | -7480.72 | -6803.95 | Upgrade
|
Gross Margin | 28.18% | 54.02% | 53.31% | 53.60% | 76.33% | 66.31% | 19.42% | 17.47% | 3.73% | -0.17% | Upgrade
|
Operating Margin | -327.19% | -200.11% | -229.10% | -98.73% | -75.15% | -120.08% | -474.04% | -467.39% | -385.97% | -531.21% | Upgrade
|
Profit Margin | -339.20% | -192.49% | -244.13% | -100.49% | -76.52% | -128.46% | -507.32% | -529.44% | -419.30% | -524.70% | Upgrade
|
Free Cash Flow Margin | -289.51% | -192.58% | -195.88% | -92.68% | -65.68% | -119.20% | -471.11% | -509.24% | -416.18% | -561.77% | Upgrade
|
EBITDA | -20.14 | -19.56 | -17.96 | -16.6 | -13.98 | -17.72 | -24.27 | -19.51 | -12.37 | -11.4 | Upgrade
|
EBITDA Margin | -316.35% | -219.60% | -210.11% | -86.45% | -64.99% | -120.08% | -472.93% | -482.84% | -371.47% | -508.39% | Upgrade
|
Depreciation & Amortization | 0.59 | 0.72 | 1.35 | 1.74 | 1.47 | 1.24 | 1.47 | 0.66 | 0.5 | 0.32 | Upgrade
|
EBIT | -20.73 | -20.28 | -19.31 | -18.34 | -15.44 | -18.96 | -25.75 | -20.18 | -12.86 | -11.72 | Upgrade
|
EBIT Margin | -325.58% | -227.70% | -225.86% | -95.48% | -71.82% | -128.49% | -501.65% | -499.23% | -386.39% | -522.44% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.